Innovation supports revenue growth acceleration in Q3
. - Revenue growth for Q3 accelerated to 5.5% (CER) lifting revenue for the first nine months to EUR 416.7 million (up…
. - Revenue growth for Q3 accelerated to 5.5% (CER) lifting revenue for the first nine months to EUR 416.7 million (up…
Two subsidiaries of Nobel Biocare, a leader in the field of innovative implant-based dental restorations, filed a compla…
Two subsidiaries of Nobel Biocare Holding AG, a world leader in the field of innovative implant-based dental restoration…
. - Revenue for the first quarter of EUR 138.8 million was up 2.8% at constant exchange rates (CER) and down 1.9% in EU…
. - Amazing new angulated screw channel concept and tooling must be experienced to be believed - New cost-effective No…
. - Revenue for Q3 was up 4.8% at constant exchange rates (CER) driving year-to-date revenue up 1.6% at CER to EUR 417.…
. - New NobelProcera® 2G System reduces scanning time up to 50%, increases business opportunities - New 'open access'…
. - Revenue for the second quarter was up 2.3% at constant exchange rates (CER) driving revenue for the first half to E…
. - Revenue for the first quarter of EUR 141.5 million was down 2.0% at constant exchange rates (CER) and down 4.1% in…
. - Nobel Biocare will establish the Foundation for Oral Rehabilitation (FOR) as a scholar-led, international initiativ…